It has been previously demonstrated that PFK inhibitor clotrimazole (CTZ) effectively compromised the ability of voltage-dependent anion channel 2 (VDAC2) to induce glioma stem cells phenotypic transition and metabolic phenotypic transition [46]. Here, VDAC2 is linked to central nervous system cancer.